For the Inventor, By the Inventor

Enter assignee name

Ipca Laboratories Limited

USPTO Granted Patents = 17

CIPO Patents = 2

EPO Patents = 3

Forward Citations = 11

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Ashok Kumar (16 out of 17 patents)

Dharmendra Singh (7 out of 7 patents)

Satish Rajanikant Soudagar (5 out of 6 patents)

4. Nellithanath Thankachen Byju (5 out of 5 patents)

5. Gaurav Sahal (3 out of 3 patents)

6. Ganesh Devidas Mahale (3 out of 3 patents)

7. Nalinakshya Balaram Panda (3 out of 3 patents)

8. Arpana Prashant Mathur (2 out of 2 patents)

9. Sanjay Pandurang Gawade (2 out of 2 patents)

10. Dinesh Kanji Bhadra (2 out of 2 patents)

11. Devki Moje (2 out of 2 patents)

12. Pramilkumar Mathur (2 out of 2 patents)

13. Abhay Atmaram Upare (2 out of 3 patents)

14. Manmohan Nimbalkar (2 out of 3 patents)

15. Swapnali Hemant Patil (2 out of 2 patents)

17 patents: Sort by Forward Citations

1. 10105353 - Anti-thrombotic compounds (2018-10-23),

2. 9492406 - Pharmaceutical composition (2016-11-15),

3. 9321785 - Methods for the treatment or prophylaxis of thrombosis or embolism (2016-04-26),

4. 8987234 - Complex for treatment and/or prophylaxis of parasitic infections (2015-03-24),

5. 8541422 - Methods for the treatment or prophylaxis of thrombosis or embolism (2013-09-24),

6. 8536337 - Solid forms of methyl (7aS,2'S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate (2013-09-17),

7. 8415360 - Pharmaceutical compositions for the treatment of diabetes mellitus (2013-04-09),

8. 7847127 - Process for preparation of atovaquone and novel intermediates thereof (2010-12-07),

9. 7847094 - Industrial preparation of 11-[4-{2-(2-hydroxyethoxy) ethyl}-1-piperazinyl] dibenzo [b,f]-[1,4]thiazepine (2010-12-07),

10. 7763748 - Process for preparation of highly pure isotretinoin (2010-07-27),

11. 7629465 - Industrial process for preparation of Clopidogrel hydrogen sulphate (2009-12-08),

12. 7615571 - Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt (2009-11-10),

13. 7547791 - One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O (2009-06-16),

14. 7459467 - Manufacturing process for methyl phenidate and intermediates thereof (2008-12-02),

15. 7414151 - Process for manufacture of 4-amino-hydroxybutylidene-1, 1-bisphosphonic acid and its salts (2008-08-19),

IPCA is a leading Indian pharmaceutical company engaged in the manufacturing and marketing of a wide range of pharmaceutical formulations, active pharmaceutical ingredients (APIs), and veterinary products. With a strong global presence, IPCA delivers quality healthcare products to millions of people across over 120 countries. The company's core focus areas include anti-malarial, pain management, anti-diarrheal, anti-infective, and cardiovascular drugs. IPCA is committed to excellence in research, development, manufacturing, and consistently meeting stringent regulatory standards to ensure the highest level of quality and patient safety.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

17 Patents

#19 in Mumbai

#108 in India

#34,877 in the World

Ipca Laboratories Limited

Forward Citations = 11

49 inventors:

Ashok Kumar (16 out of 17 patents)

Dharmendra Singh (7 out of 7 patents)

Satish Rajanikant Soudagar (5 out of 6 patents)

4. Nellithanath Thankachen Byju (5 out of 5 patents)

5. Gaurav Sahal (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…